Regression of cutaneous squamous cell carcinoma after the development of pembrolizumab‐induced bullous pemphigoid
Abstract Bullous pemphigoid is a rare complication of immune checkpoint inhibitor treatment. We report a case of pembrolizumab‐induced bullous pemphigoid in a patient with malignant melanoma and concomitant cutaneous squamous cell carcinoma that regressed. A 77‐year‐old woman with metastatic maligna...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | Livre |
Publié: |
Wiley,
2023-03-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
Cote: |
A1234.567 |
---|---|
Exemplaire 1 | Disponible |